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Abstract 
 
Recently, it was demonstrated that colorectal cancer HT-29 cells can secret 
epinephrine (adrenaline) in an autocrine manner to auto-stimulate cellular growth by 
adrenoreceptors activation, and that this secretion is enhanced by nicotine, showing an 
indirect relation between colorectal cancer and tobacco. The electrochemical behaviour of 
human colon adenocarcinoma HT-29 cells from a colorectal adenocarcinoma cell line, the 
hormone and neurotransmitter epinephrine, and nicotine, were investigated by cyclic 
voltammetry, using indium tin oxide (ITO), glassy carbon (GC) and screen printed carbon 
(SPC) electrodes. The oxidation of the HT-29 cells, previously grown onto ITO or SPC 
surfaces, followed an irreversible oxidation process that involved the formation of a main 
oxidation product that undergoes irreversible reduction, as in the epinephrine oxidation 
mechanism. The effect of nicotine stimulation of the HT-29 cells was also investigated. 
Nicotine, at different concentration levels 1, 2 and 15 mM, was introduced in the culture 
medium and an increase with incubation time, 0 to 3 h and 30 min, of the HT-29 cells 
oxidation and reduction peaks was observed. The interaction of nicotine with the HT-29 
cells stimulated the epinephrine secretion causing an increase in epinephrine release 
concentration, and enabling the conclusion that epinephrine and nicotine play an important 
role in the colorectal tumour growth. 
 
Keywords: Colon cancer HT-29 cells, epinephrine, nicotine, carbon electrodes, ITO 
electrodes. 
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1. Introduction 
 
Colorectal cancer is the third most common cancer in the world [1, 2, 3], and 
although the management of patients with colorectal cancer has changed dramatically over 
the past decade, with relevant improvement in survival [4, 5], a significant proportion of 
patients relapse after a combination of surgery and adjuvant therapies and do not respond to 
treatment in the metastatic setting [3]. Studies suggested that smokers have a higher risk for 
developing colorectal cancer cells than non-smokers [6].  
Colorectal cancer patients suffer from various forms of psychological stress 
reflected in elevated plasma catecholamines levels [7], and it has been shown that  
HT-29 human colon carcinoma cells, as well as other cancer cells, express α7-nicotinic 
acetylcholine receptor (α7-nAChR), catecholamine-synthesizing enzymes (tyrosine 
hydroxylase (TH), and DOPA decarboxylase (DDC), dopamine-β-hydroxylase (DβH), 
phenylethanolamine N-methyltransferase (PNMT) and adrenergic receptors [8, 9, 10].  
Nicotinic acetylcholine receptors (nAChRs), are ionotropic receptors that form 
ligand-gated ion channels (Na
+
, K
+
 and Ca
2+
) in the plasma membranes of certain cells.  
The catecholamine-synthesizing enzymes are important in the biosynthesis of 
epinephrine, [11], Scheme 1. Through the activated ionic channels or due to the membrane 
depolarization, Ca
2+
 can enter the cells and favour activation (i.e., phosphorylation) of the 
transcription factor CREB (cAMP response element-binding protein), which in turn 
modifies gene expression [10, 12, 13].  
 
Scheme 1. Epinephrine synthesis mechanism [11]. 
 
As a particular case, previous studies on normal and cancer cells have suggested 
that nicotine, a major active component of cigarette smoke, can regulate the expression of 
catecholamine-synthesis pathway through the action on α7-nAChR, epinephrine production 
and ultimately epinephrine release and adrenergic receptors activation [6, 13, 14], 
 Schemes 2 and 3.  
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Scheme 2. Chemotherapy resistance and cell proliferation promoted by epinephrine via nAChR activated by nicotine. 
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The α2-adrenoceptor is a transmembrane G protein-coupled receptor (GPCR) 
associated with the Gi heterotrimeric G-protein. When the α2-adrenoceptor is activated 
by epinephrine, Gi is released and inhibits the cAMP dependent pathway by inhibiting 
adenylate cyclase activity, decreasing the production of cAMP from ATP, which, in 
turn, results in a decreased activity of cAMP-dependent protein kinase [15]. The 
phospholipases pathway can also be activated by Gi. Enzymatic processing of 
phospholipids by phospholipases convert these molecules into lipid mediators or second 
messengers (such as arachidonic acid, phosphatidate and diacylglycerol) that play key 
roles in membrane trafficking, signal transduction, cell proliferation and tumour 
progression [16]. 
Moreover, it was demonstrated that stimulation of β-adrenoceptors by 
epinephrine play a role in the HT-29 cell proliferation in a dose-dependent manner and 
enhance prostaglandin-endoperoxide synthase 2 (COX-2) and vascular endothelial 
growth factor (VEGF) expression [6, 8, 17, 18]. Epinephrine at the concentration of 10 
μM significantly increased HT-29 cell proliferation by 35% when compared to the 
control group and also up-regulated matrix metallopeptidase 9 (MMP-9) activity and 
prostaglandin E2 (PGE2) release. [6, 18, 19]. 
All these effects induced by epinephrine on the physiology of cancer cells lead 
to poor response of tumours to chemotherapy, and constitute a poor prognostic factor 
for survival [18, 19]. 
Epinephrine has four polar functional groups and a small carbon skeleton. Thus, 
the polar functional groups dominate in determining the character of the molecule 
making it very polar and unlikely to pass through the cell membrane. In aqueous 
solution, the four polar groups will be highly solvated with water molecules. In order to 
cross the cell membrane, these water molecules have to be “stripped away” and this 
involves energy [20]. Following an appropriate cell stimulation (which provokes a Ca
2+
 
entry or increase) and multiple protein-protein interactions, that is, the formation of 
soluble N-ethylmaleimide sensitive fusion protein attachment receptors (SNAREs) - 
vesicle-associated membrane proteins (VAMPs) complexes, the intracellular 
epinephrine content is released to the extracellular medium [21, 22, 23]. 
Considering the existence of vesicle-associated membrane proteins (VAMPs) in 
HT-29 cells, as well as in other non-neuroendocrine cells [24, 25, 26], and the fact that 
the activation of nAChRs by nicotine results in the influx of Na
+
 and Ca
2+
, which 
engenders rapid changes in the membrane potential and local increase in intracellular  
Ca
2+
 concentration [17], it is explained the epinephrine release by HT-29 cells by a 
similar mechanism, in which nicotine play a pivotal role in chemotherapy resistance and 
cell proliferation [6, 13, 14]. 
The HT-29 colon cancer cells can produce epinephrine via catecholamine-
synthesizing enzymes (TH, DDC, DβH and PNMT) and nicotine can stimulate this 
process as well as epinephrine release. However, the expression of catecholamine-
synthesizing enzymes and epinephrine release in the extracellular medium onsets 
depends on the availability of intracellular Ca
2+
 but the composition of the external 
environment (pH, nature and concentration of ions, etc.) also plays a role. More 
generally, on a physicochemical point of view, the secretion and release efficiency and 
dynamics are finely regulated by the membrane properties (phospholipidic composition, 
mechanical tension, electrical potential, etc.) [27, 28]. The electrical properties of cell 
membrane are dependent on all the physical mechanisms, which control the mobility 
and availability of the relevant ions such as sodium, chloride, potassium, magnesium 
and calcium [29].  
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Scheme 3. Nicotine activation of acetylcholine receptors and electrochemical 
detection of epinephrine secretion. 
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In order to overtake this harmful effects and cancer progression, suitable 
procedures are required for monitoring epinephrine secretion. Several procedures based 
on quantitative gene expression analysis have already been developed and described [6, 
8, 9, 10, 13, 17, 24, 30, 31, 32]. However, these methods are expensive, time consuming 
and require skilled operators.  
The objective of this work is to investigate the epinephrine secretion of HT-29 
colon cancer cells. The electrochemical methodologies are non-morphological methods 
for following cell health state and to evaluate the effectiveness of drugs or chemical 
compounds. Moreover, the electrochemical techniques are recognized experimental 
tools for detection of cell exocytosis electroactive compounds [32, 33]. 
The electrochemical behaviour of human colon adenocarcinoma HT-29 cells 
from a colorectal adenocarcinoma cell line, the hormone and neurotransmitter 
epinephrine, and nicotine, were investigated by cyclic voltammetry (CV) using indium 
tin oxide (ITO), glassy carbon (GC) and screen printed carbon (SPC) electrodes. The 
results obtained enabled the confirmation that HT-29 can secret epinephrine in an 
autocrine manner. The effect of nicotine stimulation on epinephrine secretion and in 
HT-29 cell proliferation was also investigated electrochemically following the changes 
in the electrochemical behaviour of HT-29 cells after different incubation times with 
nicotine in the cell medium.   
 
2. Experimental 
 
2.1. Materials and reagents 
Dulbecco’s Modified Eagle Medium (DMEM) with Glutamax and foetal bovine 
serum (FBS) formulation (pH = 7.0) were purchased from Gibco-Invitrogen.  
HT-29 cell line, epinephrine and nicotine were purchased from Sigma-Aldrich. Stock 
solutions of 1.0 mM epinephrine and 62 mM nicotine in deionised water were prepared 
and diluted to the desired concentration. The other supporting electrolyte solution used 
was 0.1 M phosphate buffer pH = 7.0. All solutions were prepared using analytical 
grade reagents and purified water from a Millipore Milli-Q system (conductivity  0.1 
S cm-1). 
Microvolumes were measured using EP-10 and EP-100 Plus Motorized 
Microliter Pippettes (Rainin Instrument Co. Inc., Woburn, USA). The pH measurements 
were carried out with a Crison micropH 2001 pH-meter with an Ingold combined glass 
electrode.  
All experiments were done at room temperature, T = 298 K (25 ºC). 
 
2.2. Cell culture 
The human colon cancer cell line HT-29  was routinely grown in DMEM 
medium with FBS (10 % vol/vol), and no antibiotics supplements, onto 75 cm
2
 flasks. 
Cells were maintained at 37 ºC, in a humidified atmosphere of 5 % CO2. For the 
experiments, cells were plated on ITO and SPC working electrodes that were deposited 
on the surface of cell culture dishes until a confluent monolayer was reached (~ 48 h).  
 
2.3. Voltammetric parameters and electrochemical cells 
Voltammetric experiments were carried out using an IVIUM potentiostat in 
combination with IviumSoft program version 1.84 (Ivium Technologies, Eindhoven,  
The Netherlands). Measurements were carried out using GC (0.0176 cm
2
), SPC (0.07 
cm
2
) and ITO (~ 2 cm
2
) as working electrodes with a Pt wire counter electrode, and an 
Ag/AgCl (3 M KCl) electrode as reference, in a one-compartment electrochemical cell 
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of 2 mL capacity or directly in the cell culture dishes. The experimental conditions for 
cyclic voltammetry (CV) were scan rate 50 and 100 mV/s. 
 
2.4. Electrode surface conditioning 
 Different procedures for GC, SPC and ITO surface pre-treatments were carried 
out before every electrochemical assay, ensuring very reproducible experimental results. 
The GC electrode was polished using diamond spray (particle size 3 μm 
(Kement, Kent, UK), before every electrochemical assay. After polishing, the electrode 
was rinsed thoroughly with Milli-Q water. Following this mechanical treatment, the GC 
electrode  
was placed in phosphate buffer supporting electrolyte and CVs were recorded 
 starting at 0.0 V initial potential in the positive going direction, in the potential range  
- 0.5 V to + 1.2 V, for 5 cycles, scan rate 50 mV/s.  
The SPC electrode was pre-treated anodically by potential cycling from  
0.0 V to + 1.2 V, for 10 cycles, scan rate 100 mV/s, before every electrochemical assay 
in phosphate buffer. 
The ITO electrode was electrochemically pre-treated by potential cycling, 
starting at 0.0 V initial potential in the positive going direction, in the potential range  
- 0.5 V to + 0.8 V, for 5 cycles, scan rate 100 mV/s, before every electrochemical assay 
in phosphate buffer. 
 
3. Results and discussions 
 
3.1. Electrochemical behaviour of epinephrine and nicotine 
The electrochemical redox mechanism of epinephrine and nicotine was 
investigated by CV at GC, SPC and ITO electrodes in 0.1 M phosphate buffer pH = 7.0 
and in Dulbecco's Modified Eagle's Medium (DMEM) formulation (pH = 7.0). This 
study was a control to enable the detection of the epinephrine release by HT-29 colon 
cancer cells and the nicotine stimulation effect.  
The electrochemical behaviour of DMEM supporting electrolyte was 
investigated by CV at GC, SPC and ITO electrodes, and showed that DMEM is an inert 
electrolyte,  
Fig. 1. 
 
Here Fig. 1. 
 
3.1.1. Epinephrine  
The electrochemical behaviour of 250 µM epinephrine at a GC electrode by CV 
in phosphate buffer pH = 7.0 and in DMEM was the same, Fig. 2. On the positive going 
scan the oxidation peak 1a, at Ep1a = + 0.30 V, corresponds to the oxidation of the 
catechol moiety to ortho-quinone. Reversing the scan direction occurred a small 
cathodic peak 1c, at Ep1c = + 0.16 V, followed by the reversible 2c-2a redox couple, at 
Ep2c = - 0.18 V and Ep2a = - 0.15 V.  
 
Here Fig. 2. 
 
Epinephrine redox mechanism in physiological pH is coupled with a chemical 
reaction (Michael addition) which follows the electrochemical oxidation of the catechol 
moiety to ortho-quinone and results in cyclisation of epinephrine oxidation product and 
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adrenochrome formation, which undergoes reduction at negative potentials [34, 35], 
Scheme 4. 
 
 
 
Scheme 4. Epinephrine oxidation mechanism at physiological pH [34, 35]. 
 
The electrochemical behaviour, using CV and an ITO electrode, in 500 µM 
epinephrine in phosphate buffer pH = 7.0, and in saturated epinephrine in DMEM is a 
little different from the results obtained with the GC electrode, Fig. 3. On the positive 
going scan, potential range 0.0 V till + 0.5 V, the oxidation peak 1a, at Ep1a = + 0.38 V, 
corresponding to the oxidation of the catechol moiety to ortho-quinone was observed. 
Reversing the scan direction, from + 0.5 V till - 0.5 V, only occurs the cathodic peak 2c, 
at Ep2c = - 0.38 V, Fig. 3, corresponding to the reduction of adrenochrome formed after 
the epinephrine oxidation, Scheme 3.  
 
Here Fig. 3. 
 
Higher peak currents were obtained in the epinephrine saturated solution and a 
decrease of the oxidation peak 1a of epinephrine was observed, whereas the peak 2c 
remains constant with increasing the number of scans, Fig. 4. The electrochemical 
behaviour of 500 µM epinephrine at a SPC electrode in phosphate buffer pH = 7.0 and 
in DMEM, showed the same behaviour when compared with the results obtained at ITO 
electrode. An irreversible anodic peak 1a, at Ep1a = + 0.40 V, and after reversing the 
scan direction till - 0.5 V the cathodic peak 2c, at Ep2c = - 0.59 V, was detected. 
 
Here Fig. 4. 
 
The ITO and SPC electrodes were used in all experiments with the HT-29 cells 
due to their simplicity and flexibility to be introduced in the cell culture dishes and also 
enabling the cell growth on their electrode surface. 
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3.1.2. Nicotine  
The electrochemical behaviour of 15 mM nicotine was investigated using SPC 
and ITO electrodes in phosphate buffer pH = 7.0 and in DMEM, starting at an initial 
potential of 0.0 V, scanning in the positive direction to + 0.8 V, and after reversing the 
scan in the negative potential limit of - 0.5 V, at scan rate 100 mV/s. No oxidation or 
reduction peaks were detected showing that, in the experimental conditions used, 
nicotine is not electroactive on SPC and ITO electrodes [36, 37] 
 
3.2. Electrochemical behaviour of HT-29 cells 
The HT-29 cells in DMEM were growth onto ITO and SPC electrode surfaces. 
The first CV of HT-29 cells grown on the ITO electrode surface in DMEM, was 
recorded in the potential range 0.00 V till + 0.80 V, at 50 mV/s, Fig. 5A. Successive 
CVs showed only the irreversible anodic peak 1a, at Ep1a = + 0.42 V, and the peak 1a 
current decreased due to the adsorption of the oxidation products at the ITO electrode 
surface, Fig. 5A.  
Successive CVs were also recorded in the same HT-29 cells sample, starting at 
the 0.0 V initial potential, scanning in the positive direction to + 0.8 V and after 
reversing the scan to the negative potential of - 0.5 V, Fig. 5B. The CV showed in the 
first scan only the cathodic peak 2c, at Ep2c = - 0.38 V, Fig. 5B, followed by the anodic 
peak 1a, at Ep1a = + 0.42 V.  
 
Here Fig. 5. 
 
In other experiments, successive CVs for new HT-29 cells grown onto ITO 
electrode surface in DMEM were recorded following two steps. The first CV was 
recorded only in the cathodic region between the potentials 0.0 V to - 0.5 V, and no 
reduction peak was detected. The second CV in the same HT-29 cells was recorded in 
the potential  
range - 0.5 V to + 0.8 V, starting at 0.0 V initial potential in the positive going direction.  
The CVs, Fig. 6, showed the same behaviour as epinephrine at ITO electrode,  
Fig. 4. On the first anodic scan, one small oxidation peak 1a, at Ep1a = + 0.25 V, 
followed, in the negative going scan, by the reduction peak 2c, at Ep2c = - 0.3 V, Fig. 6.  
 
Here Fig. 6. 
 
In successive CVs, Fig. 6, the anodic and cathodic peak currents increased and 
the peak potentials were slightly shifted to more positive and negative potentials, 
respectively, and, when epinephrine was added to the HT-29 cells culture, an increase of 
HT-29 peak current was observed. 
The epinephrine adsorption onto ITO electrode during the oxidation of HT-29 
cells was also investigated. After recording several CVs of HT-29 cells grown onto ITO 
electrode surface, between the potential limits + 0.8 V till - 0.5 V in DMEM, the  
HT-29 cells were removed and the electrode was washed and then transferred to 
DMEM. On the first, positive going scan, no oxidation peak appeared; nevertheless 
reversing the scan direction the epinephrine reduction peak 2c, at Ep2c = - 0.35 V, 
occurred, showing that after the HT-29 cells were removed and the ITO electrode was 
washed only the adsorbed oxidized epinephrine product remained on the electrode 
surface. Reversing the scan direction, oxidation peak 1a, at Ep1a = + 0.3 V, occurred. 
Similar experiments were performed using SPC electrodes, Fig. 7.  
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Successive CVs were recorded for HT-29 cells grown onto the  
SPC electrode surface in DMEM, at 50 mV/s, using three different potential windows:  
(a) 0.0 V to - 0.5 V, (b) 0.0 V to + 0.8 V and (c) + 0.8 V to - 0.8 V.  
Using potential window (a) no reduction process was detected, using potential 
window (b) the CVs showed, as expected, the irreversible anodic peak 1a,  
at Ep1a = + 0.40 V and peak 1a current decreased in the successive scans, Fig. 7A. Using 
potential window (c) the CVs showed the anodic peak 1a, at Ep1a = + 0.40 V, and the 
cathodic peak 2c, at Ep2c = - 0.64 V.  
 
Here Fig. 7. 
 
The electrochemical behaviour of HT-29 cells on SPC electrode, Fig. 7, and on 
ITO electrode is the same, Fig. 6, and equal to the electrochemical behaviour of 
epinephrine on ITO and SCP electrodes, Figs. 3 and 4.  
Based on the results obtained with HT-29 cells, Figs. 5, 6 and 7, and in 
agreement with the electrochemical behaviour of epinephrine control on the ITO and 
SPC electrode surface, Figs. 3 and 4, the peak 1a corresponds to the oxidation of the 
epinephrine secreted by the HT-29 cells, Scheme 3. 
Living cells have a negative membrane potential ranging from – 100 mV for 
normal cells to very low still negative potential, for cancer cells. This negative potential 
indicates that the inside surface of the cell membrane is relatively more negative than 
the immediate exterior surface [29]. Cell receptors can be activated by electric fields 
[29], and signalling molecules such as Ca
2+
 can enter inside the cell initiating 
epinephrine release.  
When positive potentials were applied to the HT-29 cells grown on the ITO, first 
anodic scan, the HT-29 cells membrane potential was dramatically changed. In this 
way, in the first positive scan epinephrine was released and oxidized. Reversing the 
scan direction the epinephrine oxidation product adrenochrome reduction peak 2c, is 
observed, Fig. 6, and peak 1a and 2c currents increased in the successive scans, Figs. 5, 
6 and 7.  
The electrochemical behaviour of the human colon HT-29 cells grown on ITO 
and SPC electrode surface showed that epinephrine secretion play an important role in 
the colorectal tumour growth, and the effect of nicotine stimulation of epinephrine 
secretion and HT-29 cell proliferation was also investigated. The effect of the nicotine 
interaction with HT-29 cells was followed comparing the changes in the 
absence/presence of nicotine on the HT-29 cells electrochemical behaviour.  
The HT-29 cells were grown onto the ITO and SPC electrode surfaces and 
incubated for different time periods in DMEM containing 1, 2 and 15 mM nicotine. The 
interaction between 1, 2 and 15 mM nicotine and the HT-29 cells was first studied after 
short 30 min and 1 h incubation times, and no difference was detected on the HT-29 
cells redox behaviour when compared with the HT-29 cells in the absence of nicotine.  
Increasing the incubation time for 3 h 30 min, between 15 mM nicotine and the  
HT-29 cells, the CVs showed an increase of peak 1a and 2c currents, indicating that 
after a long incubation time nicotine promoted the increase of the epinephrine secreted 
by the HT-29 cells, Fig. 8.  
 
Here Fig. 8. 
 
The electrochemical results showed that during the colon cancer HT-29 cell 
culture proliferation on ITO and SPC electrode surfaces epinephrine was secreted in an 
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autocrine manner to self-stimulate cell growth via adrenoceptors, and the secretion was 
increased by the presence of nicotine via the up-regulation of the expression of the 
catecholamine-synthesizing enzymes TH, AADC, DßH and PNMT.   
 
4. Conclusions 
 
The redox behaviour of epinephrine at GC, SPC and ITO electrodes was 
investigated in 0.1 M phosphate buffer pH = 7.0 and DMEM, showing a complex 
mechanism involving the oxidation of the catechol group followed by intra-cyclization 
via Michael addition and the formation of reducible adrenochrome. 
The electrochemical study showed that colon cancer HT-29 cells secretion 
undergo oxidation on ITO and SPC electrodes, and was confirmed that epinephrine was 
secreted in an autocrine manner by the HT-29 cells. During the cellular division the 
catecholamine-synthesizing enzymes are expressed and produce epinephrine that, 
together with the applied potential to the electrode surface, favours the intracellular 
epinephrine to be released to the extracellular medium, enabling its electrochemical 
detection.  
The epinephrine secretion and release processes were stimulated by the presence 
of different concentration of nicotine, enabling the conclusion that epinephrine and 
nicotine play an important role in colorectal tumour growth. These findings are 
important in understanding the pathogenesis of colon cancer, especially related to stress, 
and can bring progresses for new non-invasive methods in development of specific 
inhibitors of colorectal cancer cell proliferation.  
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Figure Captions 
 
 
Fig 1. CVs in supporting electrolyte (▬) pH = 7.0 and () DMEM on: (A) ITO  
(B) SPC. 
 
Fig 2. CVs of epinephrine at GC electrode: (A) [epinephrine] = 250 µM at pH = 7.0 in 
[phosphate buffer] = 0.1 M and (B) [epinephrine] = 250 µM in DMEM: (▬) 
first scan, () second scan, and (▬) supporting electrolyte, = 50 mV s-1. 
 
Fig 3. CVs of epinephrine at ITO electrode: (A) [epinephrine] = 500 µM at pH = 7.0 in 
[phosphate buffer] = 0.1 M and (B) [epinephrine] = 500 µM at DMEM: (▬) first 
scan, and (▬) supporting electrolyte,  = 50 mV s-1.  
 
Fig. 4. CVs in DMEM of a saturated epinephrine solution at ITO electrode: (▬) first 
scan, and (▬) successive scans,  = 50 mV s-1. 
 
Fig. 5. Successive CVs in DMEM of HT-29 cells on ITO electrode: (A) E1= 0.0 V,  
E2 = + 0.8 V and E3 = 0.0 V, (B) E1 = 0.0 V, E2 = +0.8 V and E3 = - 0.5 V;  
E1 – initial potential, E2 – maximum potential and E3 – minimum potential.  
(▬) first scan, and (▬) successive scans,  = 50 mV s-1. 
 
Fig. 6. Successive CVs in DMEM of HT-29 cells on ITO electrode,  = 50 mV s-1.  
 
Fig. 7. Successive CVs in DMEM of HT-29 cells on SPC electrode: (A) E1 = 0.0 V,  
E2 = + 0.8 V and E3 = 0.0 V, (B) E1 = 0.0 V, E2 = +0.8 V and E3 = - 0.8 V;  
E1 – initial potential, E2 – maximum potential and E3 – minimum potential.  
(▬) first scan, and (▬) successive scans,  = 50 mV s-1. 
 
Fig. 8. CVs in DMEM of nicotine stimulated HT-29 cells on ITO electrode:  
(▬) nicotine stimulated HT-29 cells, 3 h 30 min incubation time between HT-29 
cells and [nicotine] = 15 mM, and (▬) HT-29 cells control,  = 50 mV s-1. 
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                                                                                Fig 3. 
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Fig. 4. 
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Fig. 5. 
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Fig. 6. 
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Fig. 7. 
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Fig. 8. 
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Graphical Abstract 
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Highlights 
 
 
 The electrochemical behaviour of human colon HT-29 cells was investigated. 
 
 The HT-29 cells undergo oxidation on ITO and SPC electrodes. 
 
 The oxidation is associated with the epinephrine secreted by the HT-29 cells.  
 
 The epinephrine secretion and release were stimulated by the presence of 
nicotine. 
 
 Epinephrine and nicotine play an important role in colorectal tumour growth.  
